Movement Amplification Gait Training for Stroke
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
What data supports the effectiveness of the treatment Movement Amplification Gait Training for Stroke?
Research shows that robotic-assisted gait training, which is part of Movement Amplification Gait Training, can significantly improve walking ability and muscle activation in stroke patients. Studies found that combining robotic training with motor learning tasks enhances active participation and leads to better gait and stair climbing abilities compared to traditional therapy alone.12345
Is Movement Amplification Gait Training generally safe for humans?
Movement Amplification Gait Training, also known as Robotic-Assisted Gait Training, has been associated with some adverse events like skin and tissue injuries, musculoskeletal issues, and blood pressure changes. These risks are often due to pressure and misalignments between the robot and the human body, but more detailed safety data is needed to improve safety measures.56789
How is Movement Amplification Gait Training different from other treatments for stroke rehabilitation?
Movement Amplification Gait Training is unique because it uses robotic-assisted devices to provide powered assistance during walking, allowing for untethered and more natural movement. This approach can enhance active patient participation and improve gait patterns by combining robotic support with motor learning tasks, which is different from traditional physical therapy that may not offer the same level of precision and engagement.18101112
What is the purpose of this trial?
Stroke is a leading cause of disability in the United States, affecting approximately 795,000 people annually. The Veteran's Health Administration provides over 60,000 outpatient visits for stroke-related care annually at a cost of over $250 million. Among ambulatory people with chronic stroke (PwCS), impaired balance is a common health concern that substantially limits mobility (those with the worst balance walk the least). This project will explore adaptive strategies employed by PwCS in balance challenging environments and if a novel gait training intervention using a robotic device to amplify a person's self-generated movements can improve walking balance. The development of effective interventions to increase walking balance among PwCS will positively impact Veterans' health, quality of life, and ability to participate in walking activities.
Research Team
Keith Edward Gordon, PhD
Principal Investigator
Edward Hines Jr. VA Hospital, Hines, IL
Eligibility Criteria
This trial is for individuals who have had a stroke at least 6 months ago, can walk 10 meters with or without support, and can stand for 10 minutes. It's not suitable for those in other gait/balance studies, with cognitive impairment, severe communication issues, excessive muscle stiffness in legs, serious heart/lung disease affecting walking balance, pregnancy, or use of certain braces.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Biomechanical Response Assessment
Participants undergo a single-session cross-sectional study to assess gait patterns during and immediately following walking in balance-challenging environments.
High-Intensity Gait Training
Participants engage in two high-intensity gait training sessions, one in a natural environment and the other in a Movement Amplification Environment (MAE).
Follow-up
Participants are monitored for changes in gait patterns and cardiovascular response after training sessions.
Treatment Details
Interventions
- Movement Amplification Gait Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Northwestern University
Collaborator